Pegilated interferon α2а in treatment of chronic hepatitis C

Pegilated interferon α2а in treatment of chronic hepatitis C

Aim of investigation. To analyze experience of pegIFN-α 2а (Pegasys®) application at combined antiviral therapy of chronic hepatitis C (CHC) within the framework of the Moscow regional regional program on viral hepatites treatment.Material and methods. Overall 369 patients underwent treatment since...

Full description

Saved in:

Bibliographic Details
Main Authors:	P. O. Bogomolov, S. V. Koblov, A. O. Buyeverov, M. V. Matsiyevich, O. S. Kuzmina, N. A. Barsukova, N. V. Dubinina
Format:	Article
Language:	Russian
Published:	Gastro LLC 2012-09-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	chronic hepatitis c pegilated interferon α2а treatment
Online Access:	https://www.gastro-j.ru/jour/article/view/1324
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
by: N. D. Yuschuk, et al.
Published: (2009-02-01)

The impact of genetic polymorphisms of IL28B gene on the efficacy of antiviral therapy of the chronic hepatitis C by using the standard Interferon-<i>α</i>
by: A. V. Lapshin, et al.
Published: (2013-03-01)

Results of the ORION open comparative randomized trial: evaluation of efficacy of the Russian drugs Altevir and Phosphogliv in combined treatment of chronic hepatitis C
by: V. T. Ivashkin, et al.
Published: (2012-11-01)

Safety and efficacy of telaprevir in treatment of a chronic hepatitis C in patients of the Russian population included in early access program study
by: D. T. Abrurakhmanov, et al.
Published: (2014-07-01)

Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
by: V. E. Syutkin, et al.
Published: (2011-12-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Interferon-free therapy of chronic hepatitis C: replacement of medications or new treatment paradigm?
by: S. N. Batskikh
Published: (2014-10-01)

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
by: Marina V. Mayevskaya, et al.
Published: (2018-08-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Efficacy and safety of the first domestic pegilated interferon alpha-2b «Pegaltevir» at chronic hepatitis C: pilot data of phase III clinical study
by: V. T. Ivashkin, et al.
Published: (2014-07-01)

Combination of Gilbert's syndrome and gastrointestinal diseases
by: G. M. Dubrovina, et al.
Published: (2014-09-01)

Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice
by: O. S. Shifrin, et al.
Published: (2020-04-01)

Sarcoid-like reaction at the patient with chronic hepatitis C on a background of antiviral therapy
by: A. V. Lapshin, et al.
Published: (2010-06-01)

Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome
by: Kira A Cozzolino, et al.
Published: (2025-02-01)

Efficacy and safety of 3D-therapy at HCV-related subcompensated liver cirrhosis (genotype 1b)
by: P. O. Bogomolov, et al.
Published: (2018-08-01)

Immunological Remission as a Basis for Dose Reduction of Immunosuppressors in Autoimmune Hepatitis: Results of Monocenter Surveillance Study
by: A. O. Bueverov, et al.
Published: (2024-03-01)

Evaluation of taste quality of Keemun congou black tea during ripening and the effect of this quality on antioxidant capacity and in vitro inhibition of α-amylase and α-glucosidase
by: Wenjing Huang, et al.
Published: (2025-02-01)

Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-03-01)

Practical Recommendation of the Scientific Сommunity for Human Microbiome Research (CHMR) and the Russian Gastroenterological Association (RGA) on Small Intestinal Bacterial Overgrowth in Adults
by: V. T. Ivashkin, et al.
Published: (2022-09-01)

Preliminary results of open comparative randomized study PHG-M3/P01-09 «ORION» on application of «Phosphogliv» in combined therapy of chronic hepatitis C
by: M. V. Mayevskaya
Published: (2011-06-01)

Russian interferon <i>α</i>-2b drug in the treatment of chronic hepatitis C
by: N. B. Kovaleva
Published: (2014-08-01)

Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis
by: Loïs Bolko, et al.
Published: (2025-02-01)

Refining α-synuclein seed amplification assays to distinguish Parkinson’s disease from multiple system atrophy
by: James A. Wiseman, et al.
Published: (2025-02-01)

Research progress of hypoxia-inducible factor-1α and zinc in the mechanism of diabetic kidney disease
by: Wei Qin, et al.
Published: (2025-02-01)

Lack of Tissue Virological Response as a Predictor of Relapse in Chronic Hepatitis D after Completion Bulevirtide Therapy
by: P. O. Bogomolov, et al.
Published: (2024-12-01)

Long-Term Results of the Etiotropic Therapy of Subcompensed Liver Cirrhosis in the Outcome of Chronic Hepatitis C
by: P. O. Bogomolov, et al.
Published: (2020-01-01)

TNBC response to paclitaxel phenocopies interferon response which reveals cell cycle-associated resistance mechanisms
by: Nicholas L. Calistri, et al.
Published: (2025-02-01)

Optimized production and antiviral activity evaluation of recombinant chicken interferon-alpha using an improved Baculovirus expression system
by: Yuxia Zhang, et al.
Published: (2025-03-01)

Surgical Aspects of Split Liver Transplantation: а Review
by: S. V. Gautier, et al.
Published: (2019-06-01)

Pregnancy and Healthy Childbirth in a 37 Year-Old Patient with Diverticular Disease
by: P. S. Andreev, et al.
Published: (2020-12-01)

Study insights in the role of PGC-1α in neurological diseases: mechanisms and therapeutic potential
by: Mi-bo Tang, et al.
Published: (2025-02-01)

Efficacy and safety of new protease inhibitor faldaprevir in treatment of hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-12-01)

α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation
by: Haowei Wang, et al.
Published: (2025-01-01)

Technologically-Treated Polyclonal Affinity-Purified Antibodies to the Tumor Necrosis Factor-α, Brain Specific S-100 Protein and Histamine in Treatment of Functional Dyspepsia: Results of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
by: Yu. O. Shulpekova, et al.
Published: (2022-09-01)

Hyperferritinemia at the patient with chronic hepatitis C
by: Ye. N. German, et al.
Published: (2009-02-01)

Seronegative autoimmune hepatitis
by: A. O. Buyeverov
Published: (2018-08-01)

Genetic polymorphism of xenobiotic biotransformation genes, TNF-α and IL-4 in obstructive jaundice
by: A. A. Natalsky, et al.
Published: (2015-09-01)

Comparative reducing and carbohydrate enzyme inhibitory activities of the root, leaf, and seed of Picralima nitida
by: Erwin Osiele Onyekachukwu, et al.
Published: (2025-02-01)

Hypoxia-inducible factor 1α is required to establish the larval glycolytic program in Drosophila melanogaster
by: Yasaman Heidarian, et al.
Published: (2025-03-01)

Stem cells in gastroenterology: prospects and problems
by: A. O. Buyeverov, et al.
Published: (2011-12-01)